Leukine

Active Ingredient(s): Sargramostim, GM-CSF
FDA Approved: * March 5, 1991
Pharm Company: * BERLEX LABS
Category: Cancer

Sargramostim (tradename Leukine) is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that functions as an immunostimulator. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Pharmacology 5 Chemistry 6 History 7 References Medical uses Sargramostim is primarily used for myeloid reconstitution after autologous or allogeneic bone marrow transplantation. It is also used to treat neutropenia induced by chemotherapy during the treatment of acute myeloid l... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution
NDC: 0024-5843
Labeler:
Sanofi-aventis U.S. LLC
Leukine 500 ug/ml Intravenous; Subcutaneous Liquid
NDC: 0024-5844
Labeler:
Sanofi-aventis U.S. LLC
Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution
NDC: 58468-0180
Labeler:
Genzyme Corporation
Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution
NDC: 71837-5843
Labeler:
Partner Therapeutics, Inc
Leukine 500 ug/ml Intravenous; Subcutaneous Liquid
NDC: 71837-5844
Labeler:
Partner Therapeutics, Inc